Usman Baber

19.7k citations
307 papers · 14.1k · 14 hit papers · h-index 51

Impact in

Papers in

    • Antiplatelet Therapy and Cardiovascular Diseases 113
    • Acute Myocardial Infarction Research 53
    • Cardiac Valve Diseases and Treatments 27
    • Atrial Fibrillation Management and Outcomes 22
    • Coronary Interventions and Diagnostics 83
    • Lipoproteins and Cardiovascular Health 11

Usman Baber

295 papers receiving 13.6k citations

Usman Baber's Hit Papers

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes 2025 · 155 citations
1550+4+8Years since publication50010001.5k2.0k

Peers

Usman Baber
Comparison fields: 5 of 150
  • Cardiology and Cardiovascular Medicine 6.3k
  • Internal Medicine 690
  • Surgery 3.9k
  • Hematology 1.0k
  • Genetics 657
Replace Peter Sinnaeve with:
Peter Sinnaeve Belgium
Tobias Geisler Germany
Olga Barbarash Russia
Dietrich C. Gulba Germany
Michael Twahier Nurmohamed Netherlands
Harold L. Dauerman United States
Marco Tubaro Italy
THOMAS E. MORITZ United States
Jeffrey W. Olin United States
Julio E. Núñez Spain
Usman Baber relative to Peter Sinnaeve Belgium Peter Sinnaeve's profile →
Citations per field
00.5×1.5×2.0×
Peter Sinnaeve · 1×
Citations per year

Countries citing papers authored by Usman Baber

Since Specialization
Citations

This map shows the geographic impact of Usman Baber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Usman Baber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Usman Baber more than expected).

Fields of papers citing papers by Usman Baber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Usman Baber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Usman Baber. The network helps show where Usman Baber may publish in the future.

Co-authors

The 25 scholars most cited alongside Usman Baber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Usman Baber Line = papers co-authored together Usman Baber links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 307 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Hit paper breakdown →
20172022
2
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
Hit paper breakdown →
20161067
3
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Hit paper breakdown →
2019719
4
Comparison of Propensity Score Methods and Covariate Adjustment
Hit paper breakdown →
2017563
5
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
Hit paper breakdown →
2013485
6
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
Hit paper breakdown →
2016456
7
Exome-wide association study of plasma lipids in >300,000 individuals
Hit paper breakdown →
2017437
8
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
Hit paper breakdown →
2017407
9
Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults
Hit paper breakdown →
2015373
10
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Hit paper breakdown →
2015284
11
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Hit paper breakdown →
2025244
12 2011212
13 2016200
14
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Hit paper breakdown →
2021180
15 2018173
16 2019170
17 2020166
18 2017164
19 2016160
20
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Hit paper breakdown →
2025155

About Usman Baber

Usman Baber is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Radiology, Nuclear Medicine and Imaging and Nephrology, having authored 307 papers that have together received 14.1k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (113 papers), Coronary Interventions and Diagnostics (83 papers), Acute Myocardial Infarction Research (53 papers), Cardiac Valve Diseases and Treatments (27 papers), Cardiac Imaging and Diagnostics (26 papers), Atrial Fibrillation Management and Outcomes (22 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Lipoproteins and Cardiovascular Health (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.3k citations), Internal Medicine (690 citations), Surgery (3.9k citations), Hematology (1.0k citations) and Genetics (657 citations). Usman Baber has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Roxana Mehran, Samantha Sartori, Valentı́n Fuster, George Dangas, Stuart Pocock, Annapoorna Subhash Kini, John Gregson, Samin Kumar Sharma, Daniel James Rader and Pradeep Natarajan. Their work appears in journals such as Journal of the American College of Cardiology, Catheterization and Cardiovascular Interventions, JACC: Cardiovascular Interventions, The American Journal of Cardiology and International Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact